{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:47:09Z","timestamp":1792133229106,"version":"4.4.0"},"reference-count":36,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.3724\/abbs.2026151","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:00:20Z","timestamp":1786690820000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["lncRNA CHROMR promotes DLBCL viability and invasion in an m<sup>6<\/sup>A-dependent manner"],"prefix":"10.3724","author":[{"given":"Chang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1182\/blood.2023020911","volume":"144","author":"Roschewski M","year":"2024","unstructured":"Roschewski M, Phelan JD, Jaffe ES. Primary large B-cell lymphomas of immune-privileged sites. Blood, 2024, 144: 2593-2603.","journal-title":"Blood"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa2115304","volume":"386","author":"Tilly H","year":"2022","unstructured":"Tilly H, Morschhauser F, Sehn LH, Friedberg JW, Trn\u011bn\u00fd M, Sharman JP, Herbaux C. Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma. N Engl J Med, 2022, 386: 351-363.","journal-title":"N Engl J Med"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13045-020-01011-z","volume":"13","author":"Wang L","year":"2020","unstructured":"Wang L, Li LR, Young KH. New agents and regimens for diffuse large B cell lymphoma. J Hematol Oncol, 2020, 13:","journal-title":"J Hematol Oncol"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"Jiang X","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, Yang C. The role of m6A modification in the biological functions and diseases. Sig Transduct Target Ther, 2021, 6:","journal-title":"Sig Transduct Target Ther"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"114228","DOI":"10.1016\/j.bcp.2020.114228","volume":"189","author":"Zhou Y","year":"2021","unstructured":"Zhou Y, Sun W, Qin Z, Guo S, Kang Y, Zeng S, Yu L. LncRNA regulation: new frontiers in epigenetic solutions to drug chemoresistance. Biochem Pharmacol, 2021, 189:","journal-title":"Biochem Pharmacol"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"Herman AB","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell, 2022, 82: 2252-2266.","journal-title":"Mol Cell"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tig.2021.06.014","volume":"38","author":"Kan RL","year":"2022","unstructured":"Kan RL, Chen J, Sallam T. Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends Genet, 2022, 38: 182-193.","journal-title":"Trends Genet"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"105762","DOI":"10.1016\/j.jbc.2024.105762","volume":"300","author":"Liu C","year":"2024","unstructured":"Liu C, Zhao X, Wang Z, Zhang C, Zheng W, Zhu X, Zhang D. LncRNA CHROMR\/miR-27b-3p\/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma. J Biol Chem, 2024, 300:","journal-title":"J Biol Chem"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13578-024-01225-5","volume":"14","author":"Chen T","year":"2024","unstructured":"Chen T, Zheng L, Luo P, Zou J, Li W, Chen Q, Zou J. Crosstalk between m6A modification and autophagy in cancer. Cell Biosci, 2024, 14:","journal-title":"Cell Biosci"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.7150\/jca.64061","volume":"12","author":"Zhang X","year":"2021","unstructured":"Zhang X, Liu P, Zheng X, Wang J, Peng Q, Li Z, Wei L. N6-methyladenosine regulates ATM expression and downstream signaling. J Cancer, 2021, 12: 7041-7051.","journal-title":"J Cancer"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3389\/fgene.2020.00955","volume":"11","author":"Cheng Y","year":"2020","unstructured":"Cheng Y, Fu Y, Wang Y, Wang J. The m6A methyltransferase METTL3 is functionally implicated in DLBCL development by regulating m6A modification in PEDF. Front Genet, 2020, 11:","journal-title":"Front Genet"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"623170","DOI":"10.3389\/fonc.2021.623170","volume":"11","author":"Zhang X","year":"2021","unstructured":"Zhang X, Zhong L, Zou Z, Liang G, Tang Z, Li K, Tan S. Clinical and prognostic pan-cancer analysis of N6-methyladenosine regulators in two types of hematological malignancies: a retrospective study based on TCGA and GTEx databases. Front Oncol, 2021, 11:","journal-title":"Front Oncol"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"e778","DOI":"10.1002\/ctm2.778","volume":"12","author":"Liu L","year":"2022","unstructured":"Liu L, He J, Sun G, Huang N, Bian Z, Xu C, Zhang Y. The  N6- methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma. Clin Transl Med, 2022, 12:","journal-title":"Clin Transl Med"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.7150\/ijbs.76798","volume":"19","author":"Shi J","year":"2023","unstructured":"Shi J, Zhang Q, Yin X, Ye J, Gao S, Chen C, Yang Y. Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner. Int J Biol Sci, 2023, 19: 449-464.","journal-title":"Int J Biol Sci"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12935-021-02428-3","volume":"22","author":"Yang LR","year":"2022","unstructured":"Yang LR, Lin ZY, Hao QG, Li TT, Zhu Y, Teng ZW, Zhang J. The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients. Cancer Cell Int, 2022, 22:","journal-title":"Cancer Cell Int"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Zhou Y","year":"2016","unstructured":"Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res, 2016, 44:","journal-title":"Nucleic Acids Res"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"D139","DOI":"10.1093\/nar\/gkx895","volume":"46","author":"Zheng Y","year":"2018","unstructured":"Zheng Y, Nie P, Peng D, He Z, Liu M, Xie Y, Miao Y. m6AVar: a database of functional variants involved in m6A modification. Nucleic Acids Res, 2018, 46: D139-D145.","journal-title":"Nucleic Acids Res"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/cancers15030835","volume":"15","author":"Takahara T","year":"2023","unstructured":"Takahara T, Nakamura S, Tsuzuki T, Satou A. The immunology of DLBCL. Cancers, 2023, 15:","journal-title":"Cancers"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s00277-024-05880-z","volume":"103","author":"Shi Y","year":"2024","unstructured":"Shi Y, Xu Y, Shen H, Jin J, Tong H, Xie W. Advances in biology, diagnosis and treatment of DLBCL. Ann Hematol, 2024, 103: 3315-3334.","journal-title":"Ann Hematol"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1002\/ctm2.426","volume":"11","author":"Lang C","year":"2021","unstructured":"Lang C, Yin C, Lin K, Li Y, Yang Q, Wu Z, Du H. m6A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through GF2BP2-mediated IGF1R mRNA stabilization. Clin Transl Med, 2021, 11:","journal-title":"Clin Transl Med"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood.2024026848","volume":"146","author":"De Kesel J","year":"2025","unstructured":"De Kesel J, Fijalkowski I, Pieters T, Borin C, Christensen KT, Wittouck M, Van Laere J. HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia. Blood, 2025, 146: 275-290.","journal-title":"Blood"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1182\/blood.2024027712","volume":"146","author":"Mayday MY","year":"2025","unstructured":"Mayday MY, Biancon G, Wei M, Ramirez C, Moratti I, Pintado-Urbanc AP, Espinosa JA. RBM15-MKL1 fusion protein promotes leukemia via  m6A  methylation and Wnt pathway activation. Blood, 2025, 146: 1096-1109.","journal-title":"Blood"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/s41467-025-58966-1","volume":"16","author":"Huang F","year":"2025","unstructured":"Huang F, Wang Y, Zhang X, Gao W, Li J, Yang Y, Mo H. m6A\/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability. Nat Commun, 2025, 16:","journal-title":"Nat Commun"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"e18046","DOI":"10.1111\/jcmm.18046","volume":"28","author":"Yang Q","year":"2024","unstructured":"Yang Q, Lu Y, Du A. m6A-related lncRNAs as potential biomarkers and the lncRNA ELFN1-AS1\/miR-182-5p\/BCL-2 regulatory axis in diffuse large B-cell lymphoma. J Cell Mol Medi, 2024, 28:","journal-title":"J Cell Mol Medi"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/carcin\/bgae017","volume":"45","author":"Li HB","year":"2024","unstructured":"Li HB, Wang D, Zhang Y, Shen D, Che YQ. Long noncoding RNA XIst: a novel independent prognostic biomarker for patients with ABC-DLBCL receiving R-CHOP treatment. Carcinogenesis, 2024, 45: 500-509.","journal-title":"Carcinogenesis"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00018-025-05673-1","volume":"82","author":"Hu Y","year":"2025","unstructured":"Hu Y, Yang L, Huang L, Zeng C, Ren S. m6A reader IGF2BP1 facilitates macrophage glycolytic metabolism and fibrotic phenotype by stabilizing THBS1 mRNA to promote pulmonary fibrosis. Cell Mol Life Sci, 2025, 82:","journal-title":"Cell Mol Life Sci"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1038\/s41388-025-03374-4","volume":"44","author":"Chen S","year":"2025","unstructured":"Chen S, Li T, Liu D, Liu Y, Long Z, Wu Y, Zhong Y. Interaction of PHGDH with IGF2BP1 facilitates m6A-dependent stabilization of TCF7L2 mRNA to confer multidrug resistance in gastric cancer. Oncogene, 2025, 44: 2064-2077.","journal-title":"Oncogene"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1111\/jgh.16765","volume":"39","author":"Li Y","year":"2024","unstructured":"Li Y, Chen L, Li S, Song H, Chen Y, Wang S. The m6A reader IGF2BP1 contributes to the activation of hepatic stellate cells through facilitating TUBB4B mRNA stabilization. J Gastro Hepatol, 2024, 39: 2916-2925.","journal-title":"J Gastro Hepatol"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"153758","DOI":"10.1016\/j.tox.2024.153758","volume":"503","author":"Wang J","year":"2024","unstructured":"Wang J, Guo X, Chen Y, Zhang W, Ren J, Gao A. The m6A reader IGF2BP1 attenuates the stability of RPL36 and cell proliferation to mediate benzene hematotoxicity by recognizing m6A modification. Toxicology, 2024, 503:","journal-title":"Toxicology"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"e71038","DOI":"10.1096\/fj.202501075RR","volume":"39","author":"Liu K","year":"2025","unstructured":"Liu K, Yang X, Tang X, Wang X, Tang B. IGF2BP1\/ORC1 axis influences nonsmall cell lung cancer progression via m6A methylation modification. FASEB J, 2025, 39:","journal-title":"FASEB J"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41698-025-00958-x","volume":"9","author":"Zhu C","year":"2025","unstructured":"Zhu C, Li R, You X, Xu J, Wang J, Dong D, Chen X. m6A reader IGF2BP2-stabilized lncRNA LHX1-DT inhibits renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-590-5p. npj Precis Onc, 2025, 9:","journal-title":"npj Precis Onc"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1111\/cas.16254","volume":"115","author":"Wang J","year":"2024","unstructured":"Wang J, Wang S, Yang H, Wang R, Shi K, Liu Y, Dou L. Methyltransferase like-14 suppresses growth and metastasis of non-small-cell lung cancer by decreasing LINC02747. Cancer Sci, 2024, 115: 2931-2946.","journal-title":"Cancer Sci"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.tranon.2018.07.007","volume":"11","author":"Deng W","year":"2018","unstructured":"Deng W, Clipson A, Liu H, Huang Y, Dobson R, Wang M, Johnson P. Variable responses of MYC translocation positive lymphoma cell lines to different combinations of novel agents: impact of BCL2 family protein expression. Transl Oncol, 2018, 11: 1147-1154.","journal-title":"Transl Oncol"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3324\/haematol.2016.144964","volume":"102","author":"Mathur R","year":"2017","unstructured":"Mathur R, Sehgal L, Havranek O, K\u00f6hrer S, Khashab T, Jain N, Burger JA. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs. Haematologica, 2017, 102: 373-380.","journal-title":"Haematologica"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/s41375-022-01565-6","volume":"36","author":"Zhou W","year":"2022","unstructured":"Zhou W, Xu Y, Zhang J, Zhang P, Yao Z, Yan Z, Wang H. MiRNA-363-3p\/DUSP10\/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma. Leukemia, 2022, 36: 1861-1869.","journal-title":"Leukemia"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"8063","DOI":"10.2147\/IJN.S520567","volume":"20","author":"Wang W","year":"2025","unstructured":"Wang W, Wang L, Fan Q, Xu J, Li Y, Xu J, Zhao B. Macrophage membrane-coated liposomes delivering vonoprazan disrupt mitochondrial oxidative phosphorylation in diffuse large B-cell lymphoma. Int J Nanomedicine, 2025, 20: 8063-8083.","journal-title":"Int J Nanomedicine"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/60106F88E37F43649B4AFA0D62F17401","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026151","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/60106F88E37F43649B4AFA0D62F17401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:13:13Z","timestamp":1792131193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":36,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026151","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}